Concepedia
Statistics
Publications
3
Citations
128
H-Index
Active since
2007
Affiliations
The Ohio State University(Current)
American Association of Colleges of Pharmacy
Robert C. Rengel is an author at The Ohio State University specializing in oncology, medicine, and carcinogenesis.
Publications per year
2007–2008
OSU-HDAC42, a Histone Deacetylase Inhibitor, Blocks Prostate Tumor Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model
Aaron M. Sargeant, Robert C. Rengel, Samuel K. Kulp et al. · Cancer Research · 2008 · 61 citations
Medicine, Oncology, Pharmacology +13
Chemopreventive and Bioenergetic Signaling Effects of PDK1/Akt Pathway Inhibition in a Transgenic Mouse Model of Prostate Cancer
Aaron M. Sargeant, Russell D. Klein, Robert C. Rengel et al. · Toxicologic Pathology · 2007 · 36 citations
Medicine, Oncology, Pharmacology +17
Overexpression of cyclooxygenase‐2 (COX‐2) in the mouse urinary bladder induces the expression of immune‐ and cell proliferation‐related genes
Xingya Wang, Jennifer K. Colby, Robert C. Rengel et al. · Molecular Carcinogenesis · 2008 · 31 citations
Medicine, Molecular Biology, Oncology +16
1–3 of 3